CNS Pharmaceuticals Inc (CNSP)

CNS Pharmaceuticals Inc (CNSP) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $7.8M; returns 1 day +4.6%, 1 week +2.5%, 1 year -38.3%.

CNS Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system (CNS) tumors.

Groups CNSP belongs to

• Clinical Stage Biotech
• Oncology
• CNS Disorders
• Biopharmaceutical
• Biotechnology
• Healthcare
• Pharmaceuticals
• Cancer Therapeutics
• R&D
• Life Sciences

CNSP financial model: income statement, cash flow and balance sheet